We Think Prescient Therapeutics (ASX:PTX) Can Easily Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. By way of example, Prescient Therapeutics (ASX:PTX) has seen its share price rise 157% over the last year, delighting many shareholders. Nonetheless, only a fool would ignore…
